DK1461062T3 - Sammensætning og fremgangsmåde til behandling af kronisk allontransplantatafvisning - Google Patents

Sammensætning og fremgangsmåde til behandling af kronisk allontransplantatafvisning

Info

Publication number: DK1461062T3
Authority: DK; Denmark
Prior art keywords: composition; graft rejection; treating chronic; therapeutically effective; effective amounts
Prior art date: 2001-12-05

Application number

DK02804721T

Other languages

Danish (da)

English (en)

Inventor

Daniel R Salomon

Donald V Cramer

Original Assignee

Scripps Research Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-05

Filing date

2002-12-05

Publication date

2007-01-08

2002-12-05 Application filed by Scripps Research Inst filed Critical Scripps Research Inst

2007-01-08 Application granted granted Critical

2007-01-08 Publication of DK1461062T3 publication Critical patent/DK1461062T3/da

Links

230000001684 chronic effect Effects 0.000 title abstract 2
206010052779 Transplant rejections Diseases 0.000 title 1
PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 abstract 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
229930105110 Cyclosporin A Natural products 0.000 abstract 1
108010036949 Cyclosporine Proteins 0.000 abstract 1
229960001265 ciclosporin Drugs 0.000 abstract 1
229930182912 cyclosporin Natural products 0.000 abstract 1
239000003018 immunosuppressive agent Substances 0.000 abstract 1
229940124589 immunosuppressive drug Drugs 0.000 abstract 1
210000000056 organ Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK02804721T 2001-12-05 2002-12-05 Sammensætning og fremgangsmåde til behandling af kronisk allontransplantatafvisning DK1461062T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10/006,562 US7368423B1 (en)	2001-12-05	2001-12-05	Composition and method for treating chronic allograft rejection

Publications (1)

Publication Number	Publication Date
DK1461062T3 true DK1461062T3 (da)	2007-01-08

Family

ID=21721475

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02804721T DK1461062T3 (da)	2001-12-05	2002-12-05	Sammensætning og fremgangsmåde til behandling af kronisk allontransplantatafvisning

Country Status (13)

Country	Link
US (1)	US7368423B1 (de)
EP (1)	EP1461062B1 (de)
JP (1)	JP2005530680A (de)
AT (1)	ATE340584T1 (de)
AU (1)	AU2002357062B2 (de)
CA (1)	CA2465120A1 (de)
CY (1)	CY1106242T1 (de)
DE (1)	DE60215051T2 (de)
DK (1)	DK1461062T3 (de)
ES (1)	ES2269825T3 (de)
MX (1)	MXPA04005097A (de)
PT (1)	PT1461062E (de)
WO (1)	WO2003049682A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5801534B2 (ja)	2007-01-04	2015-10-28	デビオファームインターナショナルソシエテアノニム	ウールリッヒ型先天筋ジストロフィーの処置のための、非免疫抑制性シクロスポリン

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5310732A (en) *	1986-02-03	1994-05-10	The Scripps Research Institute	2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
WO1995032718A1 (en) *	1994-05-26	1995-12-07	The Scripps Research Institute	2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease
AR006514A1 (es) *	1995-07-04	1999-09-08	Sandoz Ag	Un macrolido, sus usos, un proceso para producirlo, un aislado biologicamente puro capaz de producirlo, y una composicion farmaceutica quelo comprende
DE19547648A1 (de) *	1995-12-20	1997-06-26	Hoechst Ag	Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
JPH11228442A (ja) *	1998-02-09	1999-08-24	Cypros Pharmaceut Corp	臓器移植後のシクロスポリン投与量を低減するためのフルクトース二リン酸の使用

2001
- 2001-12-05 US US10/006,562 patent/US7368423B1/en not_active Expired - Fee Related
2002
- 2002-12-05 WO PCT/US2002/038628 patent/WO2003049682A2/en not_active Ceased
- 2002-12-05 AU AU2002357062A patent/AU2002357062B2/en not_active Ceased
- 2002-12-05 DK DK02804721T patent/DK1461062T3/da active
- 2002-12-05 DE DE60215051T patent/DE60215051T2/de not_active Expired - Lifetime
- 2002-12-05 ES ES02804721T patent/ES2269825T3/es not_active Expired - Lifetime
- 2002-12-05 CA CA002465120A patent/CA2465120A1/en not_active Abandoned
- 2002-12-05 JP JP2003550733A patent/JP2005530680A/ja active Pending
- 2002-12-05 PT PT02804721T patent/PT1461062E/pt unknown
- 2002-12-05 EP EP02804721A patent/EP1461062B1/de not_active Expired - Lifetime
- 2002-12-05 AT AT02804721T patent/ATE340584T1/de active
2004
- 2004-05-27 MX MXPA04005097A patent/MXPA04005097A/es active IP Right Grant
2006
- 2006-11-14 CY CY20061101654T patent/CY1106242T1/el unknown

Also Published As

Publication number	Publication date
DE60215051T2 (de)	2007-05-16
CY1106242T1 (el)	2011-06-08
JP2005530680A (ja)	2005-10-13
WO2003049682A3 (en)	2004-01-15
AU2002357062A1 (en)	2003-06-23
CA2465120A1 (en)	2003-06-19
MXPA04005097A (es)	2004-08-19
EP1461062A2 (de)	2004-09-29
PT1461062E (pt)	2006-12-29
ATE340584T1 (de)	2006-10-15
US7368423B1 (en)	2008-05-06
DE60215051D1 (de)	2006-11-09
HK1064610A1 (en)	2005-02-04
EP1461062A4 (de)	2005-03-16
WO2003049682A2 (en)	2003-06-19
EP1461062B1 (de)	2006-09-27
AU2002357062B2 (en)	2007-08-02
ES2269825T3 (es)	2007-04-01

Similar Documents

Publication	Publication Date	Title
DK1487493T3 (da)	2010-05-25	Konjugater af cytotoksiske midler og biologisk aktive peptider
DK0401747T3 (da)	2004-03-08	Anvendelse af rapamycin og derivater og prolægemidler deraf til fremstilling af et lægemiddel til hæmning af transplantatafstødning hos pattedyr
TNSN07304A1 (en)	2008-12-31	Combination of xolair with immunosuppressive agent
ATE424893T1 (de)	2009-03-15	Behandlung und vorbeugung von insulin- produzierende zelltransplantatabstossung
DK1339438T3 (da)	2006-02-13	Forebyggelse af transplantatafvisning i ojet
DK1539166T3 (da)	2008-10-20	Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
DK1311269T3 (da)	2012-03-26	Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem
BR0114390A (pt)	2003-08-26	éteres de 7-desmetilrapamicina
DK1509256T3 (da)	2009-11-23	Præparater og fremgangsmåde til coating af medicinske implantater
TR200101481T2 (tr)	2001-09-21	Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
NO991100L (no)	1999-05-05	Assosiasjon av NO-syntaseinhibitorer med feller for reaktive oksygenformer
DK1809320T3 (da)	2010-11-15	Præparater indeholdende lipase, protease og amylase til behandling af pankreatisk insufficiens
DK1131065T3 (da)	2003-08-25	Diakyldumarater til behandling af autoimmunsygdomme
MY144318A (en)	2011-08-29	Methods of treating hiv infection.
CL2008002380A1 (es)	2009-01-09	Composicion farmaceutica de liberacion prolongada que comprende micofenolato sodico, al menos un material de control de liberacion y opcionalmente excipientes; y su uso en el tratamiento de enfermedades que requieren de inmunosupresores, tales como trasplantes, injertos o enfermedades autoinmunes.
MA29394B1 (fr)	2008-04-01	Anticorps
DK1272169T3 (da)	2009-03-23	Anvendelse af 13-hode som regulator for vaskular biokompatibilitet og som inhibitor for cellulær hyperplasi
WO2001078653A3 (en)	2002-03-28	Graft rejection inhibition with ccr2 inhibitors
AR027240A1 (es)	2003-03-19	Combinacion de mirtazapina y gepirona para el tratamiento de la depresion y trastornos relacionados
ES2055415T3 (es)	1994-08-16	S-adenosil-metionina para el tratamiento de pancreatitis y del inmunorechazo del trasplante de pancreas.
AU6469401A (en)	2001-11-26	Pharmaceutically active compounds and methods of use
MX2026002369A (es)	2026-04-01	Compuestos antivirales y metodos de elaboracion y uso de los mismos
PT1223971E (pt)	2005-10-31	Composicoes e metodos para prevencao e tratamento da rejeicao de transplante
DK1765337T3 (da)	2009-01-05	Kombination af tenofovir, ritonavir og TMC114
CR20240365A (es)	2024-10-04	Compuestos antivirales y métodos de elaboración y uso de los mismos